Skip to main content
Clinical Trials/CTRI/2021/08/035944
CTRI/2021/08/035944
Not Yet Recruiting
N/A

Prospective evaluation of hearing status in neonatal hyperbilirubinemia

Akshay Padinharakandy0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Akshay Padinharakandy
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Akshay Padinharakandy

Eligibility Criteria

Inclusion Criteria

  • newborns and infants with history of healthy term delivery (more than 37 weeks old), near term delivery (35â??37 weeks old), average weight, hyperbilirubinemia (bilirubin more than 15 mg/dl in near term and more than 20 mg/dl in full term delivery ).

Exclusion Criteria

  • presence of neonatal hypoxia, intrauterine infections, sepsis or meningitis, infants with a family history of hearing loss, low birth weight, ototoxic medications such as aminoglycosides, congenital malformations

Outcomes

Primary Outcomes

Not specified

Similar Trials